QCM
LKFT

QRG Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

QRG Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$526K Sell
17,546
-2,159
-11% -$61.3K ﹤0.01% 847
2026
Q1 		$591K Buy
19,705
+3,535
+22% +$117K 0.01% 729
2025
Q4 		$529K Buy
16,170
+1,077
+7% +$34.8K 0.01% 743
2025
Q3 		$523K Sell
15,093
-3
-0% -$96 0.01% 699
2025
Q2 		$423K Buy
15,096
+5,399
+56% +$145K ﹤0.01% 861
2025
Q1 		$244K Sell
9,697
-758
-7% -$19.2K ﹤0.01% 962
2024
Q4 		$288K Buy
10,455
+1,866
+22% +$52K ﹤0.01% 920
2024
Q3 		$247K Buy
+8,589
New +$234K ﹤0.01% 972

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
DO
denkapparat Operations Berlin, Germany $306M AUM 40.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

QRG Capital Management's LKFT Position: Q2 2026 in Review

QRG Capital Management reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 11% in Q2 2026, selling an estimated $61.3K and leaving 17,546 shares worth $526K. The position accounts for ﹤0.01% of the portfolio, ranked #847.

QRG Capital Management first reported a position in LKFT in Q3 2024 and has held it in 8 quarters since. The position peaked at $591K in Q1 2026. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • QRG Capital Management held 17,546 shares of Lakefront Biotherapeutics American Depositary Shares worth $526K as of Q2 2026.
  • QRG Capital Management sold 2,159 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $61.3K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of QRG Capital Management's portfolio in Q2 2026, its #847 holding.
  • QRG Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2024 and has held it in 8 quarters since.
  • QRG Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $591K in Q1 2026.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.